Experimental group:Organoid drug sensitivity test was performed before treatment, and relatively sensitive treatment was adopted according to the drug sensitivity results.
Sponsors
Liaoning Cancer Hospital & Institute, Tianjin Medical University General Hospital, West China Second Hospital of Sichuan University, North China University of Science and Technology Affiliated Hospital
Conditions
Advanced CancerOvarian cancerPancreatic cancer
Early Phase 1
Canceled by the investigator. Clinical research on guiding precision treatment of pancreatic cancer patients based on organoid drug sensitivity results
Active, not recruitingChiCTR2400086544
Start: 2024-07-05Updated: 2024-09-16
Clinical Study of Transformative Therapy for Locally Advanced pancreatic cancer Based on Organoid Drug Sensitivity Results
Active, not recruitingChiCTR2400091439
Start: 2024-11-01Updated: 2024-11-04
Unknown Phase
To evaluate the value of tumor organoid drug sensitivity in guiding the prognosis of platinum-resistant recurrent ovarian epithelial carcinoma
RecruitingChiCTR2400092121
Start: 2024-06-15Updated: 2024-11-18
Clinical study on using organoid drug sensitivity test to guide precision treatment of advanced tumors
RecruitingChiCTR2500113876
Start: 2025-03-15Updated: 2025-12-08